Sipai Health Technology Co., Ltd.

As of December 31, 2025, Sipai Health Technology Co., Ltd. carries a market capitalization of 1.87B, placing it among publicly traded companies globally. Its enterprise value stands at 1.16B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sipai Health Technology Co., Ltd.'s next confirmed earnings release is scheduled for March 23, 2027.

As of December 31, 2025, Sipai Health Technology Co., Ltd. has 749.49M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Sipai Health Technology Co., Ltd. maintains a current ratio of 1.83, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Sipai Health Technology Co., Ltd.'s stock has declined approximately 46.03% over the past 52 weeks. The 50-day moving average sits at 1.51, while the 200-day moving average is 1.78.

As of December 31, 2025, Sipai Health Technology Co., Ltd. holds 687.76M in cash and equivalents against 25.13M in total debt, resulting in a net debt position of -288.40M. Total book value stands at 1.04B, with working capital of 636.91M providing operational flexibility.